Target intelligence / Profile preview

TMEM30B pseudogene 1 (TMEM30BP1)

Target
TMEM30BP1
Molecular classification
Other (pseudogene)
01

Overview

TMEM30BP1 (TMEM30B pseudogene 1) is a pseudogene related to the TMEM30B gene, which encodes the accessory beta subunit (CDC50B) of the phospholipid flippase complex (P4-ATPase family). Pseudogenes are genomic segments resembling known genes but typically lack coding potential and are not translated into functional proteins; they may arise from gene duplication or retrotransposition events[4][5]. Unlike TMEM30B, which participates in membrane lipid transport and cellular signaling, TMEM30BP1 is not known to encode a functional product or have confirmed biological activity. Pseudogenes can sometimes regulate their parent gene via RNA interactions, but there is no data supporting such a role for TMEM30BP1 at this time. TMEM30B itself is expressed in various human tissues and has roles in membrane lipid asymmetry, vesicle formation, and possibly disease, but TMEM30BP1 is not cataloged as a therapeutic target nor implicated in disease or drug interactions[1][2][3]. The existence of “TMEM30B pseudogene 1” is documented in genome annotation, but it is not considered a canonical target in pharmacology or biomedical research[4]. Confusion may arise if TMEM30BP1 is mistaken for the functional TMEM30B gene product (CDC50B), which is a membrane protein and not a pseudogene[1][2][3].

Other names
TMEM30BP1TMEM30B pseudogene 1

Beyond the preview

Go deeper on TMEM30B pseudogene 1 (TMEM30BP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM30B pseudogene 1 (TMEM30BP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call